These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31333584)
1. Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules. Hao Y; Choi Y; Babiarz JE; Kloos RT; Kennedy GC; Huang J; Walsh PS Front Endocrinol (Lausanne); 2019; 10():438. PubMed ID: 31333584 [No Abstract] [Full Text] [Related]
2. Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience. Wei S; Veloski C; Sharda P; Ehya H Cancer Cytopathol; 2019 Nov; 127(11):720-724. PubMed ID: 31536167 [TBL] [Abstract][Full Text] [Related]
3. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. Walsh PS; Wilde JI; Tom EY; Reynolds JD; Chen DC; Chudova DI; Pagan M; Pankratz DG; Wong M; Veitch J; Friedman L; Monroe R; Steward DL; Lupo MA; Lanman RB; Kennedy GC J Clin Endocrinol Metab; 2012 Dec; 97(12):E2297-306. PubMed ID: 23087323 [TBL] [Abstract][Full Text] [Related]
4. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples. Angell TE; Wirth LJ; Cabanillas ME; Shindo ML; Cibas ES; Babiarz JE; Hao Y; Kim SY; Walsh PS; Huang J; Kloos RT; Kennedy GC; Waguespack SG Front Endocrinol (Lausanne); 2019; 10():612. PubMed ID: 31572297 [No Abstract] [Full Text] [Related]
5. Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology. Yang Z; Zhang T; Layfield L; Esebua M J Am Soc Cytopathol; 2022; 11(2):74-78. PubMed ID: 34366280 [TBL] [Abstract][Full Text] [Related]
6. Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules. Angell TE; Heller HT; Cibas ES; Barletta JA; Kim MI; Krane JF; Marqusee E Thyroid; 2019 May; 29(5):650-656. PubMed ID: 30803388 [No Abstract] [Full Text] [Related]
7. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules. San Martin VT; Lawrence L; Bena J; Madhun NZ; Berber E; Elsheikh TM; Nasr CE J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665322 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules. Polavarapu P; Fingeret A; Yuil-Valdes A; Olson D; Patel A; Shivaswamy V; Matthias TD; Goldner W J Endocr Soc; 2021 Nov; 5(11):bvab148. PubMed ID: 34708178 [TBL] [Abstract][Full Text] [Related]
9. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Gortakowski M; Feghali K; Osakwe I Thyroid; 2021 Sep; 31(9):1376-1382. PubMed ID: 33764195 [No Abstract] [Full Text] [Related]
10. Comparison of Afirma Gene Expression Classifier with Gene Sequencing Classifier in indeterminate thyroid nodules: A single-institutional experience. Geng Y; Aguilar-Jakthong JS; Moatamed NA Cytopathology; 2021 Mar; 32(2):187-191. PubMed ID: 33010060 [TBL] [Abstract][Full Text] [Related]
11. Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Silaghi CA; Lozovanu V; Georgescu CE; Georgescu RD; Susman S; Năsui BA; Dobrean A; Silaghi H Front Endocrinol (Lausanne); 2021; 12():649522. PubMed ID: 34054725 [TBL] [Abstract][Full Text] [Related]
12. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience. Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499 [TBL] [Abstract][Full Text] [Related]